2010 Agenda-at-a-Glance
Day One
|
Co-Chairs' Opening Remarks |
|
|
|
Keynote Presentation: Disruptive Innovation Solutions
Healthcare must embrace disruption to achieve the innovation necessary to deal with increased regulatory scrutiny, patent expirations, higher levels of generic competition, and an aging population. Convergent medical technologies are redefining the life science sector through improved medical outcomes, improved safety, and decreased healthcare costs. |
|
|
|
Keynote Panel: Disruptive Innovation
A moderated panel will examine the topic of disruptive innovation from the perspective of senior-level medical device, biotech, and pharmaceutical executives. |
|
Networking & Refreshment Break |
|
Keynote: Shaping the Future of a New Healthcare Ecosystem
Personalized medicine represents a fundamental shift in the healthcare industry at a time when change is needed most. The unacceptable cost and efficacy of today's drugs is driving pharmacogenomic tests' strong value proposition to patients, physicians and payors. In fact, the allure of this new paradigm to create additional value and new growth opportunities is attracting new players, ranging from drug distributers to pharmacy benefits managers to entirely new enterprises (e.g. genomic benefits managers) into the fray. |
|
Keynote Panel: Enabling Healthcare Solutions
The future of healthcare is driven by technology, which is enabling disease prevention, early disease detection, more-targeted delivery, less-invasive surgical procedures, improved efficacy, and overall efficiencies. Examine whether you are truly serving the demands of your consumers with the benefits and value necessary for the consumer/patient/physician. |
|
Lunch |
|
Technology Transfer: Can Academic Institutions Bridge the Innovation Gap?
Industry and academia collaboration provides the opportunity to exchange knowledge and improve health outcomes. Examine strategies to bring translational research from academia to industry. Discuss best practices and hear what works and what doesn’t when it comes to bridging the gaps through innovation. Hear how to minimize risks, optimize value, and improve your negotiations. |
|
Keynote Panel: Convergent Medical Technologies — Success Stories
Hear success stories that address the challenges and opportunities of convergent medical technologies from conception to commercialization. Examine business models and strategies to minimize risks, cut costs, and optimize synergies. Address issues using experience-tested strategies, such as: collaborative due diligence, managing cash flow, and protecting trade secrets. |
|
Closing Remarks |
Day Two
|
Co-Chairs' Opening Remarks |
|
|
|
Keynote Presentation: Integration of Therapeutics and Diagnostics: Lessons Learned from the Front Line
Few argue that personalized medicine drives better patient care while controlling costs. However, developing, commercializing, and generating return on personalized medicine has been a dilemma for many stakeholders to date, as the success of each program is highly dependent on a number of factors that are not necessarily always aligned amongst different stakeholders. Therapeutics companies, diagnostics companies, and service providers each have different approaches and goals in helping bring personalized medicine to market, and now more than ever, are realizing the need and positive efforts of carefully crafting an internal personalized medicine strategy and working together in successful, mutually beneficial partnerships. |
|
|
|
Keynote Panel: Integration of Therapeutics and Diagnostics: Lessons Learned from the Front Line
Please join us for a lively discussion with executives from leading therapeutics, diagnostics, and life sciences companies who have spearheaded personalized medicine initiatives and have found ways to collaborate effectively and in a manner that allows maximum return. |
|
Networking Break |
|
Plenary: Trends and Best Practice in Managing the Relationship between Large Pharmaceutical Companies and Medical Device Manufacturers and CMOs
Pharmaceutical manufacturers are facing unprecedented challenges and are increasingly looking outward for new innovation and more cost effective solutions. CMOs are increasingly employed to provide flexible, economical manufacturing solutions. Key driving factors are the sale of captive facilities, cost pressures, the rising number of products in development and the growth of the biopharmaceuticals industry. All this factors require large pharmaceutical companies to rethink their relationship with their CMO supply base. |
|
Panel: Trends and Best Practice in Managing the Relationship between Large Pharmaceutical Companies and Medical Device Manufacturers and CMOs
Join senior level industry executives for insight into improved relationships between big pharmaceutical companies and their CMO / device suppliers.
Hear how leading companies address these challenges to meet their strategic objectives and manage device supplier / CMOs efficient and effectively. |
|
Lunch |
|
Plenary: Best Practices for Driving Accelerated Clinical Data Amid Health Reform
New medical technologies that improve patient outcomes remain at the heart of medical innovation. However, driving early clinical data is more challenging than ever, amid flat NIH funding, shrinking venture capital funding and more conservative conflict-of-interest rules among hospital and academic collaborations. Best practices in mapping the right combination of medical indication, regulatory path, clinical endpoints, development funding and fastest proof-of-concept data will be presented and discussed. |
|
Panel: Convergent Medical Technologies — Development to Launch
Discuss and explore key considerations to achieve optimal value for your innovation across markets. Several recent examples from personalized medicine and device sectors will be presented. |
|
Closing Remarks |
|
|
|
|
